Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Medication Safety in Polypharmacy. Geneva: World Health Organization; 2019 (WHO/UHC/SDS/2019.11). Licence: CC BY-NC-SA 3.0 IGO. https://www.who.int/docs/default-source/patient-safety/who-uhc-sds-2019-11-eng.pdf.
2. Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-834. https://doi.org/10.1001/jamainternmed.2015.0324
3. Technical overview of the Amerispeak ® panel Norc’s probability-based household panel. AmeriSpeak. Retrieved from https://amerispeak.norc.org/content/dam/amerispeak/research/pdf/AmeriSpeak%20Technical%20Overview%202019%2002%2018.pdf. Accessed 4 May 2024.
4. Reeve E, Low LF, Shakib S, Hilmer SN. Development and validation of the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913-928. https://doi.org/10.1007/s40266-016-0410-1
5. Vordenberg SE, Weir KR, Jansen J, Todd A, Schoenborn N, Scherer AM. Harm and medication-type impact agreement with hypothetical deprescribing recommendations: A vignette-based experiment with older adults across four countries. J Gen Intern Med. 2023;38(6):1439-1448. https://doi.org/10.1007/s11606-022-07850-5.